Professor Michael Ohh reviews the work and progress he and his team are making.
Kevin Carter, CEO Colorworks Canada presents Professor Ohh with a cheque for $11,500.
L-R: Darcy Maw – Barrie, Kevin Carter – CEO Colorworks Canada, Michael Ohh-University of Toronto, Rick Feltham – Oshawa, John Pito – London, Rob Wilding- Hunstville
It’s a positive trend – people wanting to address the root causes of disease by directly donating to research.
On January 20, 2015, Colorworks Express Autobody Centers, including its operating managers from Ontario and Alberta, donated $7,500 to the Department of Laboratory Medicine and Pathobiology.
100% of their donation will go towards Professor Michael Ohh who researches the common causes of cancer, including prostate, breast, colon, pancreatic and kidney cancer. Ohh believes that one of these causes is the role of hypoxia, or oxygen deprivation, in the development of cancer. By understanding the foundation of almost all cancers, he hopes to one day find better treatments and ultimately a cure.
Colorworks CEO, Kevin Carter presents our first cheque to Professor Michael Ohh
Professor Michael Ohh L-R: Rob Wilding- Hunstville, Jerry Babineau-Huntsville/Barrie Dents, John Pito-London, Kevin Carter-CEO, Rick Feltham-Oshawa, Michael Ohh-University of Toronto, Darcy Maw-Barrie, and Richard Hegerle-Chair LMP
Colorworks CEO, Kevin Carter, presenting a cheque for $25000 to the Muscular Dystrophy Asscociation to John Davidson and Jeff Preston, on behalf of Port Elgin Rotary and the Jeff Preston celebrity golf tournament, recently held at Saugeen Shores golf club in July. More than 200 golfers took part in this, the 19th annual tournament.
John Davidson is the founder of Jesse’s Journey, a small but tenacious charity forged in the name of John’s middle son, who was diagnosed with Duchenne back in the 90’s. Jesses Journey has raised over $5million for research and have established an endowment fund that is over $11million. Their goal is to raise $1million per year and so far this year, they have raised $900,000.
Kevin Carter was proud to be an organizer of this year’s golf event.
For more info on Jesses Journey, please visit www.jessesjourney.com
This year, as you know, we raised over$4000!
To donate, please visit http://moteam.co/colorworks-canada today.
On May 2nd, two students, Taylor Scholz and Colorworks founder, Don Konantz’s son, Willy Konantz started their grueling 4,500 km bike trek from London, Ontario to Vancouver, British Columbia to raise money and awareness for prostate cancer. All the money raised is going directly to the Vancouver Prostate Centre.
Here are video highlights of their incredible journey. Please watch the video then donate to this great cause.
Facebook Page: http://www.facebook.com/gearwest.fightforsomething
JULY 13, 2012 – What would it take to change the world? Rotary’s 1.2 million members believe it starts with a commitment to Service Above Self.
In more than 34,000 clubs worldwide, you’ll find members volunteering in communities at home and abroad to support education and job training, provide clean water, combat hunger, improve health and sanitation, and eradicate polio.
Colorworks CEO, Kevin Carter is a proud member of the Rotary Club.
Port Elgin Rotary made a $25,000 donation to add to their 1.1million
raised over the past 17 years toward fighting MD.
Pictured in front is Jeff Preston (local hero) and John Davidson (Jesse’s Journey). At back is Pier Donnini of Port Elgin Club and Kevin Carter, CEO of Colorworks Canada, and member of Rotary.
On November 2nd, 2011, Colorworks Express Autobody Centres founder Don Konantz spoke at the Terry Fox Foundation announcement that they are donating 12.7 million dollars for cancer research. By his own admission, Don is living proof the cancer research matters. Don was diagnosed with prostate cancer in February 2011. On that day, Don was undergoing his twelfth day of radiation treatment for lymphoma cancer that developed when his prostate cancer metastasized. Don and his family have always taken part in the Terry Fox Run to raise funds for cancer research.